Barr J.J.
22
Coauthors
5
Documentos
Volumen de publicaciones por año
Cargando gráfico
| Año de publicación | Num. Publicaciones |
|---|---|
| 2019 | 1 |
| 2021 | 3 |
| 2022 | 1 |
Publicaciones por áreas de conocimiento
Cargando gráfico
| Área de conocimiento | Num. Publicaciones |
|---|---|
| Microbiología | 9 |
| Infección | 2 |
Publicaciones por áreas temáticas
Cargando gráfico
| Área temática | Num. Publicaciones |
|---|---|
| Microorganismos, hongos y algas | 5 |
| Enfermedades | 4 |
| Farmacología y terapéutica | 1 |
| Medicina y salud | 1 |
Principales fuentes de datos
| Origen | Num. Publicaciones |
|---|---|
| Scopus | 5 |
| Google Scholar | 0 |
| RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
| Coautor | Num. Publicaciones |
|---|---|
| Fernando Gordillo Altamirano | 5 |
| Subedi D. | 2 |
| Peleg A.Y. | 2 |
| Kostoulias X. | 2 |
| Korneev D. | 2 |
| Forsyth J.H. | 1 |
| Trim M. | 1 |
| Lithgow T.J. | 1 |
| O’Bryan M.K. | 1 |
| Kielty L. | 1 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
Phage therapy in the postantibiotic era
ReviewAbstract: Antibiotic resistance is arguably the biggest current threat to global health. An increasing numberPalabras claves:Antibiotic Resistance, Bacteriophage therapy, BacteriophagesAutores:Barr J.J., Fernando Gordillo AltamiranoFuentes:scopusUnlocking the next generation of phage therapy: the key is in the receptors
ReviewAbstract: Phage therapy, the clinical use of viruses that kill bacteria, is a promising strategy in the fightPalabras claves:Autores:Barr J.J., Fernando Gordillo AltamiranoFuentes:scopusScreening for lysogen activity in therapeutically relevant bacteriophages
ArticleAbstract: Lysogenic phages can integrate into their bacterial host’s genome, potentially transferring any genePalabras claves:Acinetobacter baumannii, bacteriophage, Enterococcus faecium, Lysogeny, Phage therapy, Prophage integration, ProphagesAutores:Barr J.J., Fernando Gordillo AltamiranoFuentes:scopusPhage-antibiotic combination is a superior treatment against Acinetobacter baumannii in a preclinical study
ArticleAbstract: Background: Clinical phage therapy is often delivered alongside antibiotics. However, the phenomenonPalabras claves:Acinetobacter baumannii, Antimicrobial Resistance, Ceftazidime, Phage therapy, Phage-resistance, Preclinical study, synergismAutores:Barr J.J., Fernando Gordillo Altamirano, Korneev D., Kostoulias X., Peleg A.Y., Subedi D.Fuentes:scopusBacteriophage-resistant Acinetobacter baumannii are resensitized to antimicrobials
ArticleAbstract: We characterized two bacteriophages, ΦFG02 and ΦCO01, against clinical isolates of Acinetobacter bauPalabras claves:Autores:Archer S.K., Barr J.J., Fernando Gordillo Altamirano, Forsyth J.H., Kielty L., Korneev D., Kostoulias X., Lithgow T.J., Morris F.C., Oliveira C., O’Bryan M.K., Patwa R., Peleg A.Y., Subedi D., Trim M.Fuentes:scopus